Molecular genetics of atrioventricular septal defects

Current Opinion in Cardiology

Volumn 19, Issue 3, 2004, Pages 205-210

  Maslen, Cheryl L ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Department of Medicine L465 ^*  (United States)

Author keywords

Atrioventricular canal defect; Complex traits; Endocardial cushions; Genetic risk factors; Susceptibility genes

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN 4; COLLAGEN TYPE 6; CYSTEINE; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; TRANSCRIPTION FACTOR GATA 4; VASCULOTROPIN; WNT1 PROTEIN;

ASPLENIA; AUTOSOMAL DOMINANT DISORDER; CELL FATE; CHROMOSOME 8; CLINICAL FEATURE; CONGENITAL HEART MALFORMATION; DOWN SYNDROME; ELLIS VAN CREVELD SYNDROME; ENDOCARDIAL CUSHION DEFECT; ENDOCARDIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEART ATRIOVENTRICULAR VALVE; HEART ATRIUM SEPTUM DEFECT; HEART DEVELOPMENT; HEART SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HETEROTAXY SYNDROME; HUMAN; MCKUSICK KAUFMAN SYNDROME; MOLECULAR GENETICS; MORPHOGENESIS; NONHUMAN; NOONAN SYNDROME; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYNDROME CHARGE; TRISOMY 21;

BONE MORPHOGENETIC PROTEINS; CELL ADHESION MOLECULES; COLLAGEN; DNA-BINDING PROTEINS; EXTRACELLULAR MATRIX PROTEINS; GATA4 TRANSCRIPTION FACTOR; GENETIC PREDISPOSITION TO DISEASE; HEART SEPTAL DEFECTS, ATRIAL; HEART SEPTAL DEFECTS, VENTRICULAR; HUMANS; TRANSCRIPTION FACTORS;

EID: 2442697452     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200405000-00003     Document Type: Review

References (46)

1. Marino B, Reale A, Giannotti A, et al.: Nonrandom association of atrioventricular canal and del (8p) syndrome. Am J Med Genet 1992, 42:424-427.
2. Wilson L, Curtis A, Korenberg JR, et al.: A large, dominant pedigree of atrioventricular septal defect (AVSD) - exclusion from the Down syndrome critical region on chromosome 21. Am J Hum Genet 1993, 53:1262-1268.
3. Cousineau AJ, Lauer RM, Pierpont ME, et al.: Linkage analysis of autosomal dominant atrioventricular canal defects: exclusion of chromosome 21. Hum Genet 1994, 93:103-108.
4. Sheffield VC, Pierpont ME, Nishimura D, et al.: Identification of a complex congenital heart defect susceptibility locus by using DNA pooling and shared segment analysis. Hum Mol Genet 1997, 6:117-121.
5. Green EK, Priestley MD, Waters J, et al.: Detailed mapping of a congenital heart disease gene in chromosome 3p25. J Med Genet 2000, 37:581-587.
6. Pierpont MEM, Markwald RR, Lin AE: Genetic aspects of atrioventricular septal defects. Am J Med Genet 2000, 97:289-296.
7. Payne RM, Johnson MC, Grant JW, et al.: Toward a molecular understanding of congenital heart disease. Circulation 1995, 91:494-504.
8. Rupp PA, Fouad GT, Egelston CA, et al.: Identification, genomic organization and mRNA expression of CRELD1, the founding member of a unique family of matricellular proteins. Gene 2002, 293:47-57.
9. Robinson SW, Morris CD, Goldmuntz E, et al.: Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects. Am J Hum Genet 2003, 72:1047-1052. This article shows that mutations in CRELD1 are associated with AVSD, and that CRELD1 is the first known genetic susceptibility gene for this common heart malformation. This work provides the basis for understanding AVSD as a complex trait.
10. Kuo CT, Morrisey EE, Anandappa R, et al.: GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev 1997, 11:1048-1060.
11. Molkentin JD, Lin Q, Duncan SA, et al.: Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev 1997, 11:1061-1072.
12. Garg V, Kathiriya IS, Barnes R, et al.: GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 2003, 424:443-447. This study identifies mutations in the GATA4 gene as the monogenic cause of cardiac septal defects in two families with autosomal-dominant ostium secundum atrial septal defects. Clinical variability in affected family members suggests that GATA4 may be involved in the pathogenesis of other types of congenital heart defects.
13. Jiao K, Kulessa H, Tompkins K, et al.: An essential role of Bmp4 in the atrioventricular septation of the mouse heart. Genes Dev 2003, 15:1-6. An elegant study of the role of Bmp4 in the developing heart. This work resulted in the recognition of Bmp4 in atrioventricular valvuloseptal morphogenesis, and in the creation of a mouse model that closely mimics the phenotypic spectrum of AVSD seen in humans.
14. Skipper M: Going straight for the heart. Nat Rev Genet 2003, 4:853.
15. Abdelwahid E, Rice D, Pelliniemi LJ, et al.: Overlapping and differential localization of Bmp-2, Bmp-4, Msx-2 and apoptosis in the endocardial cushion and adjacent tissues of the developing mouse heart. Cell Tissue Res 2001, 305:67-78.
16. Korenberg JR, Bradley C, Disteche CM: Downs syndrome: molecular mapping of the congenital heart disease and duodenal stenosis. Am J Hum Genet 1992, 50:294-302.
17. Korenberg JR, Chen XN, Schipper R, et al.: Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci U S A 1984, 1:4997-5001.
18. Wright TC, Orkin RW, Destrempes M, et al.: Increased adhesiveness of Down syndrome fetal fibroblasts in vitro. Proc Natl Acad Sci U S A 1984, 81:2426-2430.
19. Kurnit DM, Aldridge JF, Neve RL, et al.: Genetics of congenital heart malformations: a stochastic model. Ann N Y Acad Sci 1985, 450:191-204.
20. Jongewaard IN, Lauer RM, Behrendt DA, et al.: Beta 1 integrin activation mediates adhesive differences between trisomy 21 and non-trisomic fibroblasts on type VI collagen. Am J Med Genet 2002, 109:298-305.
21. Gittenberger-De Groot AC, Bartram U, Oosthoek PW, et al.: Collagen type VI expression during cardiac development and in human fetuses with trisomy 21. Anat Rec 2003, 275A:1109-1116. A rare look at the expression pattern for type VI collagen in human trisomy 21 and normal fetuses.
22. Davies GE, Howard CM, Farrer MJ, et al.: Genetic variation in the Col6A1 region is associated with congenital heart defects in trisomy 21 (Down's syndrome). Ann Hum Genet 1995, 59:253-269.
23. Fairbrother U, Baptista MJ, Davies GE, et al.: Novel Col6A1 variants and congenital heart defects (CHD) in Down syndrome [abstract]. Am J Hum Genet 2003, 73(suppl):515.
24. Gaussin V, VandePutte T, Mishina Y, et al.: Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3. Proc Natl Acad Sci U S A 2002, 99:2878-2883. This study defines essential roles for the BMP receptor anaplastic lymphoma kinase (ALK)3 in cardiac morphogenesis. With the emerging roles for BMPs in the developing heart [29•,30•], it becomes apparent that genes in this pathway should be considered candidates for septal defects.
25. Schneider MD, Gaussin V, Lyons KM: Tempting fate: BMP signals for cardiac morphogenesis. Cytokine Growth Factor Rev 2003, 14:1-4. A comprehensive review of the current status of our understanding of BMP signaling during heart formation.
26. Jackson LF, Qiu TH, Sunnarborg SW, et al.: Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J 2003, 22:2704-2716. This work indicates that cardiac valve formation is dependent on activation of EGF receptor and that epidermal growth factor (EGF) receptor signaling regulates downstream signaling by BMPs.
27. Dor Y, Camenisch TD, Itin A, et al.: A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. Development 2001, 128:1531-1538.
28. Dor Y, Klewer SE, McDonald JA, et al.: VEGF modulates early heart valve formation. Anat Rec 2003, 271A:202-208. This study explores the possibility that excess vascular endothelial growth factor production caused by hypoxia causes cardiac septal defects, thereby providing a possible mechanistic explanation for the link between fetal hypoxia and endocardial cushion defects.
29. Enciso JM, Gratzinger D, Camenisch TD, et al.: Elevated glucose inhibits VEGF-A-mediated endocardial cushion formation: modulation by PECAM-1 and MMP-2. J Cell Biol 2003, 160:605-615. The work described here provides an interesting potential molecular link between gestational diabetes and an increased risk for congenital heart defects in the offspring of affected mothers.
30. Sugi Y, Ito N, Szebenyi G, et al.: Fibroblast growth factor (FGF)-4 can induce proliferation of cardiac cushion mesenchymal cells during early valve leaflet formation. Dev Biol 2003, 258:252-263. Based on an analogy between limb bud formation and endocardial cushion morphogenesis, which are both dependent on mesenchyme expansion, these investigators explore the role of fibroblast growth factors in early valve leaflet formation.
31. Yamazaki S, Iwamoto R, Saeki K, et al.: Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities. J Cell Biol 2003, 163:469-475. This study demonstrates that failure to shed an extracellular domain of a membrane-anchored protein can result in heart malformations and other developmental defects.
32. Iwamoto R, Yamazaki S, Asakura M, et al.: Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc Natl Acad Sci U S A 2003, 100:3221-3226. Abnormally thick atrioventricular valves resulted from the elimination of heparin-binding EGF activity, indicating a role for this growth factor in the control of valve morphogenesis.
33. Hurlstone AF, Haramis AP, Wienholds E, et al.: The Wnt/β-catenin pathway regulates cardiac valve formation. Nature 2003, 425:633-637. This study represents a significant advance in understanding the role of Wnt/β-catenin signaling in determining endocardial cell fate in cushion morphogenesis. In particular, the study shows that the spatial and temporal boundaries for endocardial cushion formation are regulated by control of the Wnt/β-catenin pathway.
34. Nakamura T, Sano M, Songyang Z, et al.: A Wnt- and β-catenin- dependent pathway for mammalian cardiac myogenesis. Proc Natl Acad Sci U S A 2003, 100:5834-5839. This is the first description of a role for the Wnt/β-catenin pathway in mediating cardiac differentiation.
35. Habets PE, Moorman AF, Clout DE, et al.: Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in the atrioventricular canal: implications for cardiac chamber formation. Genes Dev 2002, 16:1234-1246. This study provides a potential mechanism for the restricted pattern of expression of atrial natriuretic factor (ANF) and the maintenance of cushions as distinct developmental tissues.
36. Liu C, Liu W, Palie J, et al.: Pitx2c patterns anterior myocardium and aortic arch vessels and is required for local cell movement into atrioventricular cushions. Development 2002, 129:5081-5091. A detailed analysis of the role of the transcription factor Pitx2c in cushion morphogenesis.
37. Gitler AD, Lu MM, Jiang YQ, et al.: Molecular markers of cardiac endocardial cushion development. Devel Dyn 2003, in press. A comprehensive survey of the temporal and spatial expression patterns of a select set of genes implicated in endocardial cushion formation.
38. Stennard FA, Costa MW, Elliott DA, et al.: Cardiac t-box factor Tbx20 directly interacts with Nkx2-5, GATA4, and GATA5 in regulation of gene expression in the developing heart. Dev Biol 2003, 262:206-224. TBX20 is the most recent T-box transcription factor (T-box) transcription factor to be recognized as important in endocardial cushion development. Multiple isoforms in more advanced species may have evolved to assist in evolutionary development of the more complex vertebrate heart.
39. Camenisch TD, Spicer AP, Brehm-Gibson T, et al.: Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 2000, 106:349-360.
40. Camenisch TD, Schroeder JA, Bradley J, et al.: Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Nat Med 2002, 8:850-855. This outstanding new investigator continues to make seminal contributions to the field of cardiovascular development with a particular focus on septation and valve formation (also see [31•,32•, 33••,40••,44•]).
41. Clark EB: Epidemiology of congenital cardiovascular malformations. In Moss and Adams' heart disease in infants, children, and adolescents including the fetus and young adult. Edited by Emmanouilides GC, Allen HD, Riemenschneider TA, et al. Baltimore: Williams and Wilkins; 1995:60-70.
42. Brand T: Heart development: molecular insights into cardiac specification and early morphogenesis. Dev Biol 2003, 258:1-19. A complete review of the molecular basis of early heart development. Ideal for anyone who wants to come up to speed quickly on the details of the regulation of cardiac morphogenesis.
43. Schroeder JA, Jackson LF, Lee DC, et al.: Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling. J Mol Med 2003, 81:392-403. An outstanding review that pulls together existing data regarding complex interactions between the extracellular matrix and growth factors in the control of endocardial cushion morphogenesis.
44. Anderson RH, Webb S, Brown NA, et al.: Development of the heart: (2) septation of the atriums and ventricles. Heart 2003, 89:949-958. An excellent review of the various developmental aspects of normal and abnormal atrioventricular septation. Detailed photographs and electron micrographs of hearts help orient the reader.
45. Blom NA, Ottenkamp J, Wenink AG, et al.: Deficiency of the vestibular spine in atrioventricular septal defects in human fetuses with Down syndrome. Am J Cardiol 2003, 91:180-184. An important study investigating the morphologic basis of AVSD in Down syndrome.
46. Page GP, George V, Go RC, et al.: "Are we there yet?": deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits. Am J Hum Genet 2003, 73:711-719. This invited editorial is an excellent review of the various factors that must be considered when looking for the genes that contribute to causing complex traits. A must-read for anyone interested in the genetic basis of congenital heart defects.